OakChart

PepGen Inc

PEPGHealthcare·Biotechnology·USA·Small·NASD·Nov 11 • 3:59 PM ET

5.26+0.65 (14.10%)
2026-11-12 05:09 CET
Market cap
364.31 USD m
Revenue, TTM
0.00 USD m
Net income, TTM
-73.31 USD m
Free cash flow, TTM
-63.28 USD m
EPS diluted, TTM
-1.06
P/E
-
Compare

Price

PEPG against its 20, 50 and 200-day averages
2050200beatmiss
2.004.006.0053.3M106.5MVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26PEPGclose 5.2620-day 2.7750-day 2.74200-day 2.945.2652w low

32.6% under the 52-week high of 7.80 on 2 Jan 2026. 52-week low 1.31 on 9 Jun 2026. Last 15 sessions, 190.5% high to low

Volume 6.38× normal · the line is the 50-bar volume average

Profile

PEPG
52-week range, 61% of the way up
1.317.80

PepGen Inc. develops oligonucleotide therapies. It is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics with the goal of transforming the treatment of severe neuromuscular and neurologic diseases. The company was founded on November 9, 2020 and is headquartered in Boston, MA.

Employees56
IPOMay 06, 2022
Beta1.83
ATR, 14d0.55
Rel volume6.38
Short float5.45%
Insider own10.77%
Inst own71.79%

Snapshot

6 groups

Valuation

Index-
Market Cap364.31M
Enterprise Value275.11M
Income-73.31M
Sales0.00M
Book/sh1.49
Cash/sh1.51
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees56
IPOMay 06, 2022

Ratios

P/E-
Forward P/E-
PEG-
P/S-
P/B3.53
P/C3.48
P/FCF-
EV/EBITDA-
EV/Sales-
Quick Ratio8.70
Current Ratio8.70
Debt/Eq0.15
LT Debt/Eq0.12
Option/ShortYes / No

Earnings

EPS (ttm)-1.06
EPS next Y-1.19
EPS next Q-0.30
EPS this Y49.23%
EPS next Y-10.69%
EPS next 5Y18.40%
EPS past 3/5Y10.01% -63.43%
Sales past 3/5Y- -
EPS Y/Y TTM62.59%
Sales Y/Y TTM-
EPS Q/Q46.63%
Sales Q/Q-
EarningsNov 10 BMO
EPS/Sales Surpr.-3.44% -

Ownership

Insider Own10.77%
Insider Trans-0.02%
Inst Own71.79%
Inst Trans-5.21%
ROA-46.13%
ROE-55.07%
ROIC-63.51%
Gross Margin-
Oper. Margin-
Profit Margin-
SMA2090.10%
SMA5092.28%
SMA20079.03%
Trades-

Technical

Shs Outstand69.26M
Shs Float61.80M
Short Float5.45%
Short Ratio1.34
Short Interest3.37M
52W High7.80 -32.56%
52W Low1.31 301.53%
Volatility19.01% 11.58%
ATR (14)0.55
RSI (14)83.62
Beta1.83
Rel Volume6.38
Avg Volume2.51M
Volume16,011,680

Performance

Perf Week114.69%
Perf Month110.40%
Perf Quarter76.51%
Perf Half Y195.51%
Perf YTD-19.20%
Perf Year13.12%
Perf 3Y36.27%
Perf 5Y-
Perf 10Y-
Recom1.25
Target Price12.75
Prev Close4.61
Price5.26
Change %14.10%

Analyst ratings

latest 6 of 6
DateActionAnalystRating changeTargetImplied
Nov 10, 2026UpgradeBBofA SecuritiesUnderperform → Neutral$2.50 → $6+14.1%
Jun 16, 2026InitiatedCCraig HallumBuy$11+109.1%
Sep 09, 2025InitiatedGGuggenheimBuy$6+14.1%
Dec 16, 2024DowngradeBBofA SecuritiesNeutral → Underperform$3-43.0%
Jul 31, 2024DowngradeBBofA SecuritiesBuy → Neutral$12+128.1%
Dec 21, 2022InitiatedHH.C. WainwrightBuy$26+394.3%

Peers

Mkt cap
TickerCompanyMkt cap
TRDAEntrada Therapeutics Inc212.98M
DYNDyne Therapeutics Inc3.37B
DSGNDesign Therapeutics Inc689.67M
WVEWave Life Sciences Inc674.52M
SRPTSarepta Therapeutics Inc1.79B
STOKStoke Therapeutics Inc1.82B
SLDBSolid Biosciences Inc848.24M
EWTXEdgewise Therapeutics Inc5.21B
IONSIonis Pharmaceuticals Inc4.72B
CAPRCapricor Therapeutics Inc652.32M

Insider trading

4 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Kasraian KasraChief Technical OfficerMay 21 '26Sale1.411,2331,73950,074May 26 04:43 PM
STRECK PAULEVP, Head of R&DMar 04 '26Sale6.231,87911,70976,226Mar 06 04:14 PM
Donnelly NoelChief Financial OfficerMar 04 '26Sale6.232,08412,988111,603Mar 06 04:12 PM
McArthur James GPresident and CEOMar 04 '26Sale6.235,27532,876296,326Mar 06 04:09 PM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
IBBiShares Biotechnology ETFAUM: 11.36B
VXFVanguard Extended Market Index ETFAUM: 30.47B
IWCiShares Micro-Cap ETFAUM: 1.22B
BUSMEA Bridgeway Ultra-Small Company Market ETFAUM: 111.21M
AVSCAvantis U.S Small Cap Equity ETFAUM: 3.23B
DFSUDimensional US Sustainability Core 1 ETFAUM: 2.38B
DFASU.S. Small Cap Portfolio-ETF Class SharesAUM: 15.51B
DFAUDimensional US Core Equity Market ETFAUM: 12.85B
DXUVUS Vector Equity Portfolio ETF Class SharesAUM: 665.71M

News

latest 14 of 100

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-11-10-0.280-0.271-0.2800.000.008
2026Q22026-08-06-0.260-0.285-0.2570.000.008
2026Q12026-05-12-0.260-0.293-0.2570.000.006
2025Q42026-03-04-0.270-0.353-0.2670.000.006
2025Q32025-11-12-0.520-0.565-0.5250.000.006
2025Q22025-08-07-0.700-0.846-0.7050.000.005
2025Q12025-05-08-0.920-0.721-0.9240.000.005
2024Q42025-02-24-0.680-0.814-0.6820.000.005
2024Q32024-11-07-0.660-0.869-0.6560.000.005
2024Q22024-08-08-0.870-0.722-0.8730.000.005
2024Q12024-05-14-0.627-0.685-0.6290.000.004
2023Q42024-03-06-0.813-0.938-0.8190.000.005
2023Q32023-11-08-0.980-0.884-0.9790.000.005
2023Q22023-08-08-0.820-0.808-0.8210.000.005
2023Q12023-05-11-0.690-0.792-0.6870.000.005
2022Q42023-03-23-0.625-0.872-0.6300.000.005

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2021FY-30.005--1.2180.00-
2022FY-4.424-4.748-2.9140.000.00
2023FY-3.303-3.430-3.3040.000.00
2024FY-2.850-2.730-2.8490.000.00
2025FY-2.120-2.266-2.1200.000.00
2026FY--1.076--0.00
2027FY--1.191--0.00
2028FY--1.152--0.00
2029FY--0.928--33.29
2030FY--0.448--88.53

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-107000.000.000.00
2026Q4S2026-08-067000.000.000.00
2026Q4S2026-06-157000.000.000.00
2026Q4S2026-06-046000.000.000.00
2026Q4S2026-05-215000.000.000.00
2026Q4S2026-05-134000.000.000.00
2026Q4S2026-03-274000.000.000.00
2026Q4S2026-03-053000.000.000.00
2026Q4S2025-11-122000.000.000.00
2026Q4S2025-11-112000.000.000.00
2026Q4S2025-11-102000.000.000.00
2026Q4R2026-11-10402-0.36-0.56-0.23
2026Q4R2026-10-21400-0.35-0.53-0.21
2026Q4R2026-10-20410-0.35-0.53-0.21

Estimate history

EPS, annual-0.06-0.182-1.218-2.914-3.304-2.849-2.123-1.0611
Period2019202020212022202320242025TTM
EPS, quarterly-0.656-0.682-0.924-0.705-0.525-0.267-0.257-0.257-0.28
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual00000000
Period2019202020212022202320242025TTM
Sales, quarterly000000000
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual22.39322.39322.39323.71323.82332.6268.87569.261
Period2019202020212022202320242025MRQ
Shares, quarterly32.5932.6232.72132.868.74768.87569.16869.2669.261
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Total Revenue0.000.000.000.000.000.000.000.00
Cost of Goods Sold Incl. D&A1.161.401.501.180.490.180.110.11
Gross Profit-1.16-1.40-1.50-1.18-0.49-0.18-0.11-0.11
Selling, General and Administrative Excl. Other76.8192.2296.2383.5867.8126.931.771.25
Research and Development52.7069.6574.9766.9453.5818.820.910.62
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-77.97-93.61-97.74-84.77-68.30-27.11-1.88-1.35
Interest Expense0.000.000.000.000.000.000.000.00
Unusual Expense0.000.000.000.000.000.000.000.00
Net Income Before Taxes-73.21-89.61-90.60-78.55-65.40-27.28-1.89-1.35
Income Taxes0.080.05-0.620.073.710.000.000.00
Consolidated Net Income-73.31-89.66-89.98-78.63-69.10-27.28-1.89-1.35
Net Income From Continuing Operations-73.31-89.66-89.98-78.63-69.10-27.28-1.89-1.35
Net Income-73.31-89.66-89.98-78.63-69.10-27.28-4.08-1.35
EPS (Recurring)-1.06-2.12-2.85-3.30-2.91-1.22-0.18-0.06
EPS (Basic, Before Extraordinaries)-1.06-2.12-2.85-3.30-2.91-1.22-0.18-0.06
EPS (Diluted)-1.06-2.12-2.85-3.30-2.91-1.22-0.18-0.06
EBITDA-76.81-92.22-96.23-83.58-67.81-26.93-1.77-1.25
Non-Operating Income (Expense)4.764.017.146.212.90-0.17-0.010.01
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense9.148.389.055.573.761.530.12-
Shares Outstanding69.2668.8732.6223.8223.7122.3922.3922.39
Market Capitalization364.31364.31123.54161.93315.96315.96--

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue0.000.000.000.000.000.000.000.00
Cost of Goods Sold Incl. D&A0.200.300.320.340.340.330.390.38
Gross Profit-0.20-0.30-0.32-0.34-0.34-0.33-0.39-0.38
Selling, General and Administrative Excl. Other20.1818.6418.6219.3718.3223.6030.9323.96
Research and Development14.2812.2212.6913.5213.0818.0624.9918.58
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-20.38-18.94-18.94-19.70-18.65-23.93-31.32-24.34
Interest Expense0.000.000.000.000.000.000.000.00
Unusual Expense0.000.000.000.000.000.000.000.00
Net Income Before Taxes-19.38-17.80-17.75-18.29-18.03-23.09-30.20-22.86
Income Taxes0.010.020.000.050.000.000.00-0.62
Consolidated Net Income-19.39-17.81-17.76-18.34-18.03-23.09-30.20-22.24
Net Income From Continuing Operations-19.39-17.81-17.76-18.34-18.03-23.09-30.20-22.24
Net Income-19.39-17.81-17.76-18.34-18.03-23.09-30.20-22.24
EPS (Recurring)-0.28-0.26-0.26-0.27-0.52-0.70-0.92-0.68
EPS (Basic, Before Extraordinaries)-0.28-0.26-0.26-0.27-0.52-0.70-0.92-0.68
EPS (Diluted)-0.28-0.26-0.26-0.27-0.52-0.70-0.92-0.68
EBITDA-20.18-18.64-18.62-19.37-18.32-23.60-30.93-23.96
Non-Operating Income (Expense)1.001.141.191.410.630.841.121.49
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense2.342.622.261.932.382.363.430.94
Shares Outstanding69.2669.2669.1768.8768.7532.8032.7232.62
Market Capitalization364.31124.50122.33447.55151.5336.3245.93123.54

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Cash & Short Term Investments148.46120.19110.41181.75132.909.783.49
Short Term Receivables0.000.000.000.064.740.410.23
Inventories0.000.000.000.000.000.000.00
Other Current Assets2.513.572.274.272.350.130.05
Total Current Assets150.96123.76112.68186.08139.9910.323.77
Net Property, Plant & Equipment21.0225.1528.3829.880.640.320.42
Total Investments and Advances1.551.551.551.471.470.000.00
Intangible Assets---0.00-0.000.00
Other Assets0.370.430.440.001.550.000.00
Total Assets173.91150.88143.05217.44143.6410.644.19
Short Term Debt Incl. Current Port. of LT Debt3.193.093.005.550.000.000.00
Accounts Payable0.821.751.001.363.240.720.14
Income Tax Payable--0.003.25---
Other Current Liabilities8.6411.8513.528.667.080.120.18
Total Current Liabilities12.6516.7017.5318.8310.320.840.33
Long Term Debt13.8215.5717.1018.980.000.000.00
Provision for Risks Charges0.000.000.000.000.000.000.00
Other Liabilities0.000.000.000.000.230.030.00
Total Liabilities26.4632.2634.6337.8110.550.870.33
Non-Equity Reserves0.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.00165.1816.130.00
Common Equity147.44118.62108.42179.63-32.08-6.363.87
Total Shareholders Equity147.44118.62108.42179.63133.099.773.87
Accumulated Minority Interest0.000.000.000.000.000.000.00
Total Equity147.44118.62108.42179.63133.099.773.87
Total Liabilities & Stockholders Equity173.91150.88143.05217.44143.6410.644.19
Book Value Per Share2.143.644.557.58-1.43-0.280.17
Tangible Book Value Per Share2.143.644.557.58-1.43-0.280.17
Full-Time Employees568164453123-
Price to Book Ratio3.530.901.291.631.63--
Return on Assets-55.21-61.23-43.62-38.28-35.36-25.47-
Return on Equity-67.39-79.26-54.59-44.19-38.19-27.70-
Return on Invested Capital-55.60-67.06-62.64-34.79-20.50-19.33-34.81
Quick Ratio11.947.416.439.8813.5612.3111.58
Current Ratio11.947.416.439.8813.5612.3111.58

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY
Net Income-73.31-89.66-89.98-78.63-69.10-27.28-1.89-1.35
Depreciation1.151.401.501.180.490.180.110.11
Other Funds (Non Cash)11.9512.8511.356.494.841.730.120.00
Funds from Operations-60.20-75.41-77.13-70.95-63.77-25.37-1.66-1.24
Extraordinary Item0.000.000.000.000.000.000.000.00
Changes in Working Capital-3.05-6.22-5.251.954.512.770.010.35
Cash from Operating Activities-63.25-81.64-82.37-69.00-59.27-22.60-1.65-0.89
Capital Expenditures-0.03-0.26-0.50-2.60-3.75-0.50-0.01-0.03
Net Assets From Acquisitions0.000.000.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.000.00
Purchase or Sale of Investments-58.73-14.97-37.17-29.400.000.000.000.00
Purchase of Investments-187.73-93.97-145.17-29.400.000.000.000.00
Sale Or Maturity of Investments129.0079.00108.000.000.000.000.000.00
Other Uses0.000.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.00
Cash from Investing Activities-58.76-15.23-37.67-32.00-3.75-0.50-0.01-0.03
Cash Dividends Paid0.000.000.000.000.000.000.000.00
Change in Capital Stock1.07107.9888.75-0.19112.19147.667.952.79
Repurchase of Common Pref Stock0.000.000.000.000.000.000.000.00
Sale of Common Pref Stock1.07107.9888.75-0.19112.19147.667.952.79
Proceedsfrom Stock Options1.07107.9888.75-0.19111.98147.667.952.79
Issuance or Reduction of Debt, Net0.000.000.000.000.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.120.000.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.000.000.00
Cash from Financing Activities1.20107.9888.75-0.19112.19147.667.952.79
Exchange Rate Effect-0.00-0.02-0.060.29-0.320.03-0.010.06
Net Change in Cash-120.8211.09-31.35-100.9048.86124.596.291.94
Free Cash Flow-63.28-81.90-82.87-71.60-63.02-23.10-1.66-0.91
Preferred Dividends (Cash Flow)-0.000.000.000.000.00-0.00
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments104.81117.24132.30148.46163.6674.65
Short Term Receivables0.000.000.000.000.000.00
Inventories0.000.000.000.000.000.00
Other Current Assets2.763.091.972.512.542.83
Total Current Assets107.57120.33134.27150.96166.2177.49
Net Property, Plant & Equipment18.4019.2520.0921.0221.9322.78
Total Investments and Advances1.551.551.551.551.551.55
Other Assets0.270.270.390.370.370.43
Total Assets127.78141.40156.29173.91190.06102.24
Short Term Debt Incl. Current Port. of LT Debt3.263.233.213.193.163.14
Accounts Payable1.911.090.620.820.770.86
Other Current Liabilities7.204.685.138.648.7112.36
Total Current Liabilities12.369.018.9612.6512.6416.36
Long Term Debt12.3512.8613.3513.8214.2814.72
Provision for Risks Charges0.000.000.000.000.000.00
Other Liabilities0.000.000.000.000.000.00
Total Liabilities24.7121.8622.3226.4626.9231.08
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity103.07119.53133.98147.44163.1471.16
Total Shareholders Equity103.07119.53133.98147.44163.1471.16
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity103.07119.53133.98147.44163.1471.16
Total Liabilities & Stockholders Equity127.78141.40156.29173.91190.06102.24
Book Value Per Share1.491.731.942.142.372.17
Tangible Book Value Per Share1.491.731.942.142.372.17
Full-Time Employees---56--
Price to Book Ratio3.530.930.832.742.130.40
Return on Assets-46.13-59.06-54.44-55.21-51.93-65.54
Return on Equity-55.07-75.45-68.40-67.39-62.25-85.69
Return on Invested Capital-16.80-13.45-12.06-11.37-10.16-26.88
Quick Ratio8.7013.3614.9811.9413.154.74
Current Ratio8.7013.3614.9811.9413.154.74

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income-19.39-17.81-17.76-18.34-18.03-23.09
Depreciation0.240.250.320.340.340.33
Other Funds (Non Cash)3.023.362.972.603.023.54
Funds from Operations-16.13-14.20-14.47-15.40-14.66-19.22
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital2.95-1.60-3.95-0.44-4.59-4.38
Cash from Operating Activities-13.18-15.81-18.43-15.85-19.26-23.60
Capital Expenditures0.00-0.030.000.00-0.10-0.04
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments12.46-3.49-1.46-66.2519.0015.00
Purchase of Investments-18.54-53.49-28.46-87.250.000.00
Sale Or Maturity of Investments31.0050.0027.0021.0019.0015.00
Other Uses0.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities12.46-3.52-1.46-66.2418.9014.96
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock-0.09-0.171.51-0.17108.050.10
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock-0.09-0.171.51-0.17108.050.10
Proceedsfrom Stock Options-0.09-0.171.51-0.17108.050.10
Issuance or Reduction of Debt, Net0.000.000.000.000.000.00
Change in Long Term Debt0.000.000.000.000.000.00
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt0.000.000.000.000.000.00
Net Financing Active Other Cash Flow0.000.110.010.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.00
Cash from Financing Activities-0.09-0.071.52-0.17108.050.10
Exchange Rate Effect-0.000.000.00-0.000.01-0.01
Net Change in Cash-0.81-19.39-18.36-82.26107.70-8.56
Free Cash Flow-13.18-15.84-18.43-15.84-19.36-23.64

Revenue breakdown

Revenue split-

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-305.45%3.4M61.8M941.63K
2026-10-156.16%3.8M61.8M857.49K
2026-09-306.84%4.2M61.8M990.76K
2026-09-156.26%3.9M61.8M960.56K
2026-08-315.98%3.7M61.8M922.01K
2026-08-147.11%4.4M61.8M927.58K
2026-07-316.76%4.1M60.8M868.26K
2026-07-157.47%4.5M60.7M894.55K
2026-06-306.59%4.0M60.7M1.37M
2026-06-156.35%3.9M60.7M1.36M
2026-05-296.17%3.7M60.7M1.45M
2026-05-155.70%3.5M60.8M1.39M
2026-04-305.25%3.2M61.0M1.38M
2026-04-155.86%3.6M60.9M1.38M
2026-03-315.65%3.4M60.9M1.17M
2026-03-135.50%3.3M60.9M712.23K
2026-02-274.36%2.7M60.9M663.70K
2026-02-134.71%2.9M60.6M764.98K
2026-01-304.68%2.8M59.4M706.55K
2026-01-154.35%2.6M59.4M713.36K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call0.503.206.804.050.00031.000.000.990-0.0120.000
call1.002.606.203.600.00049.000.000.983-0.0130.000
call1.502.505.803.150.00043.000.000.976-0.0130.000
call2.002.503.802.558.7076080.000.969-0.0130.001
call3.002.102.752.105.4525,40546.000.950-0.0120.001
call4.001.051.801.343.7274672550.914-0.0110.001
call5.000.450.900.582.4033,1812,5100.633-0.0260.003
call6.000.200.300.251.7161,4725220.361-0.0300.003
call7.000.050.100.051.6298094020.159-0.0180.002
call8.000.000.250.072.10250356.000.132-0.0210.002
call9.000.000.900.172.49151.000.000.117-0.0230.002
call10.000.000.100.132.4322601.000.066-0.0140.001
call11.000.003.400.002.6970.000.000.061-0.0150.001
call12.000.003.400.002.9330.000.000.057-0.0160.001
put0.500.000.050.029.66329.000.00-0.010-0.0120.000
put1.000.000.050.086.00471.000.00-0.020-0.0110.000
put1.500.000.050.034.47614.000.00-0.029-0.0110.000
put2.000.000.050.053.9961650.00-0.031-0.0130.001
put3.000.000.050.052.49539317.00-0.050-0.0120.001
put4.000.000.400.051.407632321-0.086-0.0100.001
put5.000.200.250.251.1564,7151,745-0.367-0.0250.003
put6.000.851.000.851.603549845-0.639-0.0290.003
put7.001.352.151.802.8484.00102-0.841-0.0180.002
put8.000.604.703.468.30710.000.00-0.868-0.0200.002
put9.001.605.304.547.54521.000.00-0.883-0.0220.002
put10.002.606.300.007.9720.000.00-0.934-0.0130.001
put11.003.707.300.008.3420.000.00-0.939-0.0140.001
put12.004.708.300.008.6690.000.00-0.943-0.0140.001

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-10424B5SEC
2026-11-108-KCurrent report2026-11-10SEC
2026-11-1010-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-08-068-KCurrent report2026-08-06SEC
2026-08-0610-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-06-224Statement of changes in beneficial ownership of securities2026-06-18SEC
2026-06-224Statement of changes in beneficial ownership of securities2026-06-18SEC
2026-06-224Statement of changes in beneficial ownership of securities2026-06-18SEC
2026-06-224Statement of changes in beneficial ownership of securities2026-06-18SEC
2026-06-224Statement of changes in beneficial ownership of securities2026-06-18SEC
2026-06-224Statement of changes in beneficial ownership of securities2026-06-18SEC
2026-06-224Statement of changes in beneficial ownership of securities2026-06-18SEC
2026-06-224Statement of changes in beneficial ownership of securities2026-06-18SEC
2026-06-228-KCurrent report2026-06-18SEC
2026-05-264Statement of changes in beneficial ownership of securities2026-05-21SEC
2026-05-21EFFECTEffectiveness filing by commission orderSEC
2026-05-218-KCurrent report2026-05-21SEC
2026-05-19CORRESPSEC
2026-05-18S-3Registration statement for specified transactions by certain issuers including face-amount certificate companiesSEC
2026-05-15SCHEDULE 13G/ASEC
2026-05-15SCHEDULE 13G/ASEC
2026-05-128-KCurrent report2026-05-12SEC
2026-05-1210-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-04-28ARSAnnual report to security holders. 2025-12-31SEC
2026-04-28DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-04-28DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-06-18SEC
2026-04-17UPLOADUpload SubmissionSEC
2026-04-15DRSSEC
2026-03-308-KCurrent report2026-03-30SEC
2026-03-11SCHEDULE 13GSEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-05001.74K1
2026-040000
2026-030057.57K3
2026-020000
2026-010000
2025-120000
2025-110000

Institutional holders

Manager% owned
RA CAPITAL MANAGEMENT, L.P.29.01%
Commodore Capital LP6.47%
VIKING GLOBAL INVESTORS LP5.03%
Laurion Capital Management LP3.97%
ADAR1 Capital Management, LLC3.75%
Vivo Capital, LLC3.36%
VANGUARD CAPITAL MANAGEMENT LLC2.80%
MILLENNIUM MANAGEMENT LLC2.58%
RENAISSANCE TECHNOLOGIES LLC2.20%
BlackRock, Inc.1.89%

Funds

Fund% owned
VANGUARD TOTAL STOCK MARKET INDEX FUND2.04%
VANGUARD EXTENDED MARKET INDEX FUND0.70%
iShares Biotechnology ETF0.65%
Fidelity Extended Market Index Fund0.34%
iShares Micro-Cap ETF0.20%
Fidelity Total Market Index Fund0.12%
Ultra-Small Company Market Fund0.12%
U.S. SMALL CAP PORTFOLIO0.11%
Fidelity Series Total Market Index Fund0.10%
Avantis U.S. Small Cap Equity ETF0.06%

OakChart. PEPG. Cached 15 minutes.